Loading…
Pluri Inc. is projected to decline to $1.66 by 2027, a -3% move from its current price of $1.72. PLUR is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $1.65 | $1.71 | $1.78 | -0.02% |
| Jul 14 | $1.63 | $1.71 | $1.81 | -0.03% |
| Jul 15 | $1.61 | $1.71 | $1.83 | -0.05% |
| Jul 16 | $1.59 | $1.71 | $1.84 | -0.07% |
| Jul 17 | $1.58 | $1.71 | $1.86 | -0.09% |
| Jul 18 | $1.57 | $1.71 | $1.87 | -0.10% |
| Jul 19 | $1.55 | $1.71 | $1.89 | -0.12% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.55 | $1.71 | $1.89 | -0.12% |
| Week 2 | $1.49 | $1.71 | $1.96 | -0.24% |
| Week 3 | $1.44 | $1.71 | $2.02 | -0.36% |
| Week 4 | $1.40 | $1.71 | $2.07 | -0.48% |
| Week 5 | $1.37 | $1.70 | $2.12 | -0.60% |
| Week 6 | $1.34 | $1.70 | $2.16 | -0.72% |
| Week 7 | $1.31 | $1.70 | $2.20 | -0.84% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Pluri Inc. is a biotechnology company engaged in the research, development, and manufacture of cell-based products, cell therapeutics, and related technologies for various industries. It develops placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions, and operates an immunotherapy platform.
Its product candidates include PLX-PAD, composed of maternal mesenchymal stromal cells originating from the placenta for the treatment of various indications, and PLX-R18, composed of fetal MSC like cells originating from the placenta for the treatment of hematopoietic complications of the H-ARS, and an allogeneic MAIT cell therapy platform. The company also offers cell manufacturing services and cell-based coffee, and develops and commercializes cultivated meat products. It operates in the field of regenerative medicine, food tech, immunotherapy, CDMO, and AgTech.
It has a collaboration agreement with Bar-Ilan University to advance cancer immunotherapy for solid tumors. The company was formerly known as Pluristem Therapeutics Inc. and changed its name to Pluri Inc.
in July 2022. Pluri Inc. was incorporated in 2001 and is based in Haifa, Israel.
Pluri Inc. (PLUR) is currently trading at $1.71 per share, with a market capitalization of $18.45M and a rank of 4906. The asset carries a year-by-year forecast that places 2026 at a neutral stance with a min of $1.71, an avg of $1.71, and a max of $2.23.
The long-range view shows potential upside, culminating in a 2050 max of $11.27 and an avg of $5.40, corresponding to a 215.7% ROI. The forecast reflects a trajectory from a neutral near-term outlook toward higher price levels later in the horizon, though individual years carry varying ROIs and sentiment.
A major floor 26.5% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.3% away) — a key level to hold.
The nearest ceiling, 40.5% above — a clean break opens room to run.
A major ceiling 111.1% above — clearing it would confirm fresh momentum.
Key PLUR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PLUR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.93 | Sell | $1.88 | Sell |
| MA 10 | $2.01 | Sell | $1.97 | Sell |
| MA 20 | $2.09 | Sell | $2.10 | Sell |
| MA 50 | $2.55 | Sell | $2.44 | Sell |
| MA 100 | $2.98 | Sell | $2.81 | Sell |
| MA 200 | $3.31 | Sell | $3.27 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 26.79 | Buy |
| Stoch RSI (14) | 7.55 | Buy |
| CCI (20) | -220.85 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -18.10 | Sell |
| Bollinger %B (20,2) | -0.11 | Buy |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -1.00 | Sell |
| Awesome (5,34) | -0.27 | Sell |
| Ultimate (7,14,28) | 24.14 | Buy |
| Momentum (10) | -0.44 | Sell |
| Aroon Osc (25) | -84.00 | Sell |
| Hull MA (9) | 1.78 | Sell |
| ADX (14) | 33.14 | Sell |
| ATR (14) | 0.08 | Info |
The 30-day technical picture is NEUTRAL, with RSI14 at 30. The 50-day moving average is $2.55 and the 200-day moving average is $3.31, indicating near-term price action remains constrained relative to longer-term averages. There is immediate support at $1.72 and resistance at $2.41.
The 30-day price range spans from a low of $1.34 to a high of $2.18. The stock exhibits high volatility, with annualized volatility at 70%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.72 | $1.72 | $2.23 | 0% | Neutral | |
| $1.28 | $1.66 | $2.30 | -3% | Neutral | |
| $1.20 | $1.62 | $2.36 | -5% | Neutral | |
| $1.16 | $1.62 | $2.44 | -6% | Neutral | |
| $1.40 | $2.01 | $3.13 | +17% | Neutral | |
| $1.53 | $2.26 | $3.62 | +32% | Bullish | |
| $1.48 | $2.24 | $3.66 | +30% | Bullish | |
| $1.42 | $2.19 | $3.67 | +28% | Bullish | |
| $1.28 | $2.04 | $3.47 | +19% | Neutral | |
| $1.35 | $2.19 | $3.80 | +27% | Bullish | |
| $1.60 | $2.86 | $5.36 | +67% | Bullish | |
| $2.51 | $5.41 | $11.29 | +215% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.72 | $1.72 | $2.02 | +0.00% |
| August 2026 | $1.43 | $1.70 | $2.09 | -0.97% |
| September 2026 | $1.40 | $1.69 | $2.11 | -0.60% |
| October 2026 | $1.33 | $1.61 | $2.04 | -4.42% |
| November 2026 | $1.34 | $1.63 | $2.09 | +1.30% |
| December 2026 | $1.41 | $1.73 | $2.23 | +5.89% |
Click any year to see its month-by-month PLUR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Pluri Inc.'s 2026 outlook centres on $1.72, within a $1.72 to $2.23 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, PLUR could reach as high as $2.30, with a base case around $1.66 and support toward $1.28 — roughly -3% from $1.72. A consolidation phase looks the most probable path here.
Expect PLUR to range from $1.20 to $2.36 through 2028. The $1.62 average target implies a -5% move from current prices. That is -2% versus the projected 2027 average. Price action looks broadly range-bound.
The PLUR price prediction for 2029 points to an average of $1.62 (low $1.16, high $2.44) — a potential decline of -6% on today's $1.72. A consolidation phase looks the most probable path here.
In 2030, PLUR is projected to trade between $1.40 and $3.13, averaging $2.01 — a potential gain of +17% from today's $1.72. That is up +24% on the projected 2029 average. Price action looks broadly range-bound.
Pluri Inc.'s 2031 outlook centres on $2.26, within a $1.53 to $3.62 range. That is up +12% on the projected 2030 average. That marks a +32% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, PLUR could reach as high as $3.66, with a base case around $2.24 and support toward $1.48 — roughly +30% from $1.72. Momentum favours further upside here.
Expect PLUR to range from $1.42 to $3.67 through 2033. The $2.19 average target implies a +28% move from current prices. That is -2% versus the projected 2032 average. Buyers look set to stay in control over this stretch.
The PLUR price prediction for 2034 points to an average of $2.04 (low $1.28, high $3.47) — a potential gain of +19% on today's $1.72. Price action looks broadly range-bound.
In 2035, PLUR is projected to trade between $1.35 and $3.80, averaging $2.19 — a potential gain of +27% from today's $1.72. That is up +7% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Pluri Inc.'s 2040 outlook centres on $2.86, within a $1.60 to $5.36 range. That is up +31% on the projected 2035 average. That marks a +67% change versus current levels. Momentum favours further upside here.
By 2050, PLUR could reach as high as $11.29, with a base case around $5.41 and support toward $2.51 — roughly +215% from $1.72. Buyers look set to stay in control over this stretch.
Investing $1,000 in PLUR today (≈ 583.090379 PLUR) could be worth
$3,151.91
+$2,151.91 (+215%) by 2050 · US Dollar
Based on the average projected PLUR price of $5.41 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PLURwould be worth at today's price.
$1,000 invested in PLUR on Jul 10, 2025 (≈ 184.842889 PLUR) would be worth
$317.01
-$682.99 (-68.3%) today · 0.32× · US Dollar
Based on a PLUR entry price of $5.41 vs. today's $1.72.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.11 | $812.8 | -18.7% |
| 1 month ago | $2.26 | $758.85 | -24.1% |
| 3 months ago | $3.32 | $516.57 | -48.3% |
| 6 months ago | $3.13 | $547.92 | -45.2% |
| 1 year ago | $5.41 | $317.01 | -68.3% |
| All time (5.0y) ago | $29.28 | $58.57 | -94.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PLUR forecast.
Our base-case forecast reaches $3.40 around 2050.
Implied market cap at $3.40: $36.68M
The multi-year forecast shows a path from a flat near-term performance to higher price levels by the end of the horizon. In 2026 the avg price is $1.71 with a min of $1.71 and a max of $2.23, and a 0% ROI. By 2030 the avg rises to $2.01 with a min of $1.40 and a max of $3.12, corresponding to a 17.3% ROI.
In 2031 the avg is $2.26 (min $1.53, max $3.61) with a 32.2% ROI, followed by 2032 at $2.23 (min $1.47, max $3.65) and a 30.3% ROI, and 2033 at $2.18 (min $1.41, max $3.65) with 27.6% ROI. The forecast for 2034 shows $2.03 as the avg (min $1.28, max $3.47) and 18.9% ROI, while 2035 projects $2.18 (min $1.35, max $3.79) with 27.5% ROI. The outlook then strengthens toward 2040 with an avg of $2.86 and a 67% ROI, and culminates in 2050 with an avg of $5.40, a min of $2.50, a max of $11.27, and a 215.7% ROI.
Sentiment shifts to BULLISH in 2031, 2032, 2033, 2035, 2040, and 2050, reflecting growing confidence over the longer horizon. These figures are estimates and not guarantees, and actual results may differ.
Tap a question to reveal the answer.
The forecast shows min $1.40, avg $2.01, max $3.12 with ROI 17.3% and sentiment NEUTRAL.
The outlook is mixed: 2026-2029 show ROI of 0%, -3.6%, -5.4%, and -5.6% respectively, while 2031-2035 and beyond show higher ROIs (32.2%, 30.3%, 27.6%, 27.5%) and bullish sentiment in several years, indicating potential upside but with significant variability.
Yes. The 2050 forecast lists a max of $11.27.
Current price is $1.71 and market capitalization is $18.45M.
Min $1.53, avg $2.26, max $3.61, ROI 32.2%, sentiment BULLISH.
Pluri Inc. Community Discussion
0Share your Pluri Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.